UNRESECTABLE LOCALLY RECURRENT RECTAL CANCER
Clinical trials for UNRESECTABLE LOCALLY RECURRENT RECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE LOCALLY RECURRENT RECTAL CANCER trials appear
Sign up with your email to follow new studies for UNRESECTABLE LOCALLY RECURRENT RECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation plus immunotherapy offers new hope for hard-to-treat rectal cancer
Disease control Recruiting nowThis study tests a new treatment for people whose rectal cancer has returned and cannot be surgically removed. The approach combines targeted radiation (SBRT) with an immunotherapy drug (PD-1 antibody) to try to shrink tumors and improve survival. About 31 participants will recei…
Matched conditions: UNRESECTABLE LOCALLY RECURRENT RECTAL CANCER
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 07:09 UTC
-
New hope for inoperable rectal cancer: targeted radiation trial launches
Disease control Recruiting nowThis study tests a high-precision radiation treatment called SBRT for people with rectal cancer that has returned after initial treatment and cannot be removed by surgery. The goal is to see if SBRT can stop the tumor from growing for at least a year and improve survival. About 4…
Matched conditions: UNRESECTABLE LOCALLY RECURRENT RECTAL CANCER
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated May 15, 2026 11:56 UTC